Impact of regular enteral feeding via jejunostomy during neo-adjuvant chemotherapy on body composition in patients with oesophageal cancer

Figure 1 Radiologic image showing a comparison of body composition at diagnosis (A) and post neo-adjuvant (B) chemotherapy (two computed tomography scans of the third lumbar vertebra skeletal mass) for the same patient. Red: Muscle; Yellow: Visceral fat; Blue: Subcutaneous fat.

Figure 2 Overall change in body composition from diagnosis to after neo-adjuvant chemotherapy. A: Skeletal muscle index; B: Adipose tissue index.

Figure 3 Individual changes in lumbar skeletal muscle index (cm²/m²) from diagnosis to after neo-adjuvant chemotherapy following regular enteral feeding via jejunostomy.

Figure 4 Individual changes in lumbar adipose tissue index (cm²/m²) from diagnosis to after neo-adjuvant chemotherapy following regular enteral feeding via jejunostomy.